89% of individuals with positive multitarget stool DNA tests get colonoscopy: 4 insights | Janssen Pharmaceuticals' ulcerative colitis drug induces clinical remission | Learn how to revolutionize ASC procedure documentation with AI and the cloud at Becker's ASC 25th Annual Meeting l HCA, Dignity Health and Tenet among 1,299 providers to join BPCI Advanced

Oct. 11, 2018

Today's Top Stories

1. 89% of individuals with positive multitarget stool DNA tests get colonoscopy: 4 insights Full story

2. Janssen Pharmaceuticals' ulcerative colitis drug induces clinical remission Full story

3. HCA, Dignity Health and Tenet among 1,299 providers to join BPCI Advanced
Full story

4. Revolutionizing ASC procedure documentation with AI and the Cloud - attend this special session at the Becker's ASC 25th Annual Meeting on Oct. 19, 12:20-1:20 p.m. To attend, contact Jessica Lanzon at jlanzon@beckershealthcare.com.

5. Better communication can reduce medical errors. The right technology can make a difference. For insights, download this free white paper. Click here.

6. Allergan, Takeda & more - 7 GI company key notes
Full story

7. GI leader to know: Dr. Khaled Issa of Cleveland Clinic's North Ohio Gastroenterology Full story

8. Bridge the gap and assure true interoperability with an enterprise imaging solution. For a breakdown of key enterprise imaging considerations, click here.